Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study

Michael R. McClung, Andreas Grauer, Adolfo Díez‐Pérez et al.|Journal of Bone and Mineral Research|2018

Cited by 237